Pharmacy Times

JUNE 23, 2025

1 Image credit: Cynthia | stock.adobe.com The discussion featured Vivian Fonseca, MD, of the Tulane University School of Medicine, who presented an overview of tirzepatide based on the FDA-approved label and clinical guidelines. May 16, 2022. 1 “[Tirzepatide] has been a tool that has helped me get my blood glucose under control.

Diabetes

Pharmacy Times

JUNE 12, 2025

November 16, 2022. Primary chemoablation of recurrent low-grade intermediate-risk nonmuscle-invasive bladder cancer with UGN-102: A single-arm, open-label, phase 3 trial (ENVISION). Global research trends in non-muscle invasive bladder cancer: Bibliometric and visualized analysis. Front Oncol. doi:10.3389/fonc.2022.1044830

Pharmacy Technician

Pharmacy Times

AUGUST 6, 2025

The CARTITUDE-1 trial reported a 98% overall response rate and significant progression-free survival, but experts urge caution in labeling cilta-cel as a cure. 1 Image Credit: LASZLO | stock.adobe.com However, despite these promising data, experts are cautious about labeling the therapy a cure.

Pharmacy Technician

BioPharma Dive

JUNE 11, 2025

The company scrapped its initial drug program in 2022 and changed course two years later when a second prospect disappointed. Based on conversations with physicians, it “could be positioned well, and ahead of Augtyro,” he wrote, adding that Wednesday’s sell off in shares was “overdone on any potential launch and label optics concerns.”

Drug Pricing

Pharmaceutical Technology

JULY 15, 2025

LEO’s new asset is a monoclonal antibody that blocks the activation of the interleukin-36 (IL-36) receptor – a key signalling pathway in the immune system implicated in the pathogenesis of several autoinflammatory diseases. It has also been approved in expanded indications in GPP in certain territories.

Packaging

The Thyroid Pharmacist

MARCH 7, 2025

1] This inability to detox properly can trigger or worsen autoimmune symptoms, as these chemical exposures can trigger immune dysregulation. [2] to fluoride in my tap water, to hidden mold in my home, to my shampoo and deodorant (have you ever read those labels?!), From indoor pollutants like formaldehyde (yes, really!),

Health and Personal Care Stores

Pharmaceutical Technology

AUGUST 14, 2025

Dupixent, first approved for EoE in adults and adolescents in 2022 then expanded in 2024 to treat children as young as one, has quickly established itself as a first-line biologic due to its strong efficacy, favourable safety profile and biweekly subcutaneous administration.

Insurance Coverage and Processing

Digital Pharmacist

OCTOBER 24, 2022

Date of Approval: 9/30/2022. Date of Approval: 9/29/2022. Date of Approval: 9/22/2022. Date of Approval: 9/21/2022. Date of Approval: 9/14/2022. Date of Approval: 9/9/2022. Below we will be listing some of the new drug therapy advances and approvals that the FDA had in the month of September.

Adverse Reactions

Express Pharma

APRIL 17, 2023

Prometheus is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialisation of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases.

Immunity

Pharmaceutical Technology

JANUARY 23, 2023

The management of SLE and LN consists largely of treatment options that are based on highly efficacious steroids or immune-suppressive therapy with an undesirable safety profile, which includes accrued organ damage, infections and cancer. in 2018 across the 7MM despite being an off-label therapy for lupus.

Labelling

pharmaphorum

FEBRUARY 9, 2022

Using a vaccine to utilise the patient’s own immune system to fight cancer is particularly attractive because of the targeted approach made possible by this technology. While therapeutic cancer vaccines are able to help the body identify particular proteins expressed by cancer cells and then to instigate an immune response.

Vaccines

pharmaphorum

APRIL 23, 2021

Calliditas Therapeutics is on course to launch its first product, Nefecon for rare disease primary IgA nephropathy (IgAN), in the first half of 2022 after getting the green light for an accelerated review by the EMA. . The post Calliditas eyes 2022 approval in EU for rare kidney disease drug Nefecon appeared first on.

Labelling

FDA Law Blog: Biosimilars

APRIL 30, 2023

Senate Committee on Health, Education, Labor and Pensions (“Senate HELP”) is scheduled to take up legislation that could significantly limit access to the courts and immunize critical FDA decisions from timely judicial review. 1067, which first reared its head in Spring 2022 as an amendment to S.4348, Shumsky — On May 2nd, the U.S.

Immunity

European Pharmaceutical Review

FEBRUARY 7, 2023

PVR blockade by NTX1088 is the first and only therapeutic approach aiming at restoring the antitumor immune activity of DNAM1 (CD226). The Phase I , open label clinical trial was initiated in November 2022. KEYTRUDA is MSD’s anti-PD1 therapy, in patients with locally advanced and metastatic solid tumours.

Immunity

The Thyroid Pharmacist

JUNE 30, 2023

However, low doses of this medication (hence, low dose naltrexone or LDN), have been found to modulate the immune system and have shown promise in improving cases of autoimmune disease. These include Crohn’s, MS, and Hashimoto’s, as well as other immune system-related conditions such as cancer and HIV/AIDS. Doses of 1.5-4.5

Compounding

European Pharmaceutical Review

FEBRUARY 22, 2023

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. 2022 [cited 2023Feb]. No serious adverse events were reported.

Biosimilars

Express Pharma

OCTOBER 11, 2024

The matter at hand From corner stores to high-end pharmacies, shelves are increasingly stocked with an array of colorful bottles promising everything from enhanced immunity to Herculean strength. For example, The FSS (Nutra) Regulations, 2022, aim to prevent disease cure claims, but many companies still make such assertions.

Labelling

pharmaphorum

SEPTEMBER 11, 2022

Analysts at Mizuho have suggested that competition from BMS’ drug could trim Otezla’s 2025 sales from $3 billion to $2 billion, although Amgen is attempting to defend its product by expanded the label of the drug to include mild psoriasis. It had been approved since 2014 for moderate to severe cases only.

Labelling

pharmaphorum

DECEMBER 12, 2022

Dutch biotech Argenx is on course to add another rare disease indication to the label of its FcRn blocker Vyvgart – primary immune thrombocytopenia (ITP) – thanks to new data reported at the ASH annual meeting. The post ASH: Argenx cues up a second use for efgartigimod appeared first on.

Immunity

European Pharmaceutical Review

OCTOBER 19, 2023

The development of novel radiotherapeutics ushered in a new era in targeted treatment 1 for cancer, with two separate radiotherapeutic approvals in Europe and the US, in 2018 and 2022. Recent advancements for radiopharmaceuticals in oncology include a $1.4

Chemotherapy

pharmaphorum

SEPTEMBER 16, 2022

Findings presented at EADVC 2022. Almirall has previously found state-of-the-art therapies for immune-related inflammatory diseases such as hidradenitis suppurativa, alopecia areata, psoriasis, and vitiligo.

Medical Schools

The Thyroid Pharmacist

OCTOBER 7, 2022

I knew he was right — sugar can contribute to a yeast overgrowth, lowered immunity, blood sugar issues, weight gain, diabetes, and a whole host of health problems (1-3) — but I was a sugar addict, and it was devastating to think that I would have to let go of this old friend and not have any sweetness in my life. What About Other Sweeteners?

Diabetes

Pharmaceutical Technology

MARCH 6, 2023

Adverse events (AEs) were balanced between the arms, except for immune-related AEs, which were more frequent in the Tuoyi arm (grade ≥ 3, 8.9% Keytruda has a HNSCC-wide label in combination with platinum and fluorouracil in the first-line setting and is sometimes used in patients with NPC. versus 1.4%).

Chemotherapy

The Thyroid Pharmacist

AUGUST 19, 2022

8) In very simple terms, this theory hypothesizes that our immune system begins to attack our own thyroid gland because we are infected with a pathogenic organism (like a bacterium, parasite , or virus ), that looks similar to components of the thyroid gland. Molecular mimicry is one of the leading theories of autoimmune disease. (8)

Health and Personal Care Stores

The Thyroid Pharmacist

OCTOBER 25, 2022

Fibrocystic breasts used to be labeled as a disease, but given how common they are, they’re now simply referred to as “fibrocystic breasts.” (7) Published 2022 Jul 12. Published 2022 Jul 12. Accessed September 27, 2022. Accessed September 27, 2022. link] Accessed August 12, 2022. Consider Lifestyle Changes.

Compounding

Pharmaceutical Technology

APRIL 24, 2023

With early nanoparticle studies, researchers often found the human body’s innate immune response to drugs and the short-lasting effects of drugs challenging, as they can also reduce a drug’s efficacy. Since then, the drug has been used off-label in breast cancer and other types of cancer.

Vaccines

The Thyroid Pharmacist

SEPTEMBER 6, 2023

Furniture and Electronics Containing Fire-retardant Chemicals Flame retardants have been associated with worsening thyroid function, impacts on the immune system, adverse effects on fetal and child development, changes in neurologic function, and even cancer. (6) Accessed April 18, 2022. Endocrine Research. 2015;40(4):204-210.

Health and Personal Care Stores

PharmaShots

JANUARY 23, 2023

However, AhR is found throughout the body, including in immune and skin cells, and is thought to play a significant role in maintaining skin homeostasis. VTAMA cream’s active ingredient, tapinarof, is an aryl hydrocarbon receptor (AhR) agonist, and VTAMA cream is the first and only FDA-approved AhR agonist in the U.S.

Labelling

The Thyroid Pharmacist

JULY 1, 2022

Check food labels carefully, and be extra careful if you are eating out, as it’s difficult to know all of the ingredients used in restaurants. Accessed June 20, 2022. Intestinal immune regulation as a potential diet-modifiable feature of gut inflammation and autoimmunity. UpToDate, 2022. Accessed June 22, 2022.

Labelling

The Thyroid Pharmacist

AUGUST 18, 2023

Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a randomized open-label parallel-arm study. Accessed 24 May, 2022. This would make a daily dose of 1600 mg of spirulina, 200 mg of curcumin, and 200 mg of boswellia, respectively. 2019;69:1-8. doi:10.1016/j.nutres.2019.05.001; 2019;20(1):214. Cancer Res Treat.

Dosage

The Thyroid Pharmacist

OCTOBER 28, 2022

This irritation can interrupt the immune system’s ability to regulate itself, and put the body into a perpetual “attack mode” that is counterproductive to healing. Immune system health and gut health are linked. They can help improve digestion and nutrient extraction from the foods we eat, and can also balance the immune system.

Health and Personal Care Stores

The Thyroid Pharmacist

DECEMBER 7, 2022

Several years ago, after reading research about all of the toxins commonly used in flame retardants (and learning about all of the many products in my home that contain these chemicals… somewhat of a shocking list), I looked at my mattress label, only to learn it contained one of the chief offenders. Labels (Furniture, Fabrics, and Carpet).

Health and Personal Care Stores

The Thyroid Pharmacist

JULY 29, 2022

Breathing in pollutants is inflammatory, and triggers an immune response as the body tries to process out the toxins. Perhaps more concerning, of the 133 different VOCs found across all tested products, only one, ethanol, was actually listed on any label! (13, But formaldehyde has been labeled as a known human carcinogen by the U.S.

Health and Personal Care Stores

The Thyroid Pharmacist

OCTOBER 6, 2023

Histamine is an important chemical in the immune system that is released by cells during hypersensitivity or inflammatory reactions. [1] Histamine is an important chemical in the immune system that is released by cells during hypersensitivity or inflammatory reactions. [1] One form of treatment for allergies is an allergy shot.

Health and Personal Care Stores

European Pharmaceutical Review

SEPTEMBER 15, 2022

At week 24, the open-label extension (Period 2) began, and all patients were treated with Skyrizi. New data from the open-label extension period revealed that at 100 weeks, 64 and 57 percent of patients initially treated with Skyrizi achieved ACR20 response in KEEPsAKE 1 and 2, respectively. The two studies are ongoing. .

Labelling

The Thyroid Pharmacist

JULY 14, 2023

TGF-β modulates inflammation and helps to induce and maintain the “tolerance of self” (which means the immune system is more capable of recognizing itself and less likely to attack itself), thus also reducing thyroid autoimmunity. Individual doctors may still be able to utilize this therapy with their patients as an “off-label” use.

Dosage

The Thyroid Pharmacist

AUGUST 5, 2022

Threonine: Supports central nervous, cardiovascular, liver, and immune system functioning. Glutamine: This amino acid helps repair intestinal permeability ( leaky gut ) and boosts immune function. First, many of the essential and non-essential amino acids are required for thyroid function, gut repair, and immune function.

Immunization